Mark L. Smythe
Chief Executive Officer chez Infensa Bioscience Pty Ltd.
Profil
Mark L.
Smythe is the founder of Protagonist Therapeutics, Inc. which was founded in 2006.
He held the title of Vice President-Technology from 2013 to 2022.
Currently, he is the Chief Executive Officer at Infensa Bioscience Pty Ltd.
since 2022.
He previously worked at GSK Plc as a Principal.
Dr. Smythe obtained a doctorate from the University of Melbourne and an undergraduate degree from James Cook University.
Postes actifs de Mark L. Smythe
| Sociétés | Poste | Début |
|---|---|---|
| Infensa Bioscience Pty Ltd. | Chief Executive Officer | 01/05/2022 |
Anciens postes connus de Mark L. Smythe
| Sociétés | Poste | Fin |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Founder | 01/05/2022 |
| GSK PLC | Corporate Officer/Principal | - |
Formation de Mark L. Smythe
| University of Melbourne | Doctorate Degree |
| James Cook University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GSK PLC | Health Technology |
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Infensa Bioscience Pty Ltd. |
